Digital Mental Health Treatments: The Role Of Neurobehavioral Therapies In MDD
There is a significant unmet need for patients with Major Depressive Disorder (MDD) who fail to achieve an adequate response to current treatments. As our understanding of the biology of depression evolves, novel treatment targets are emerging. Neurobehavioral therapies (NBTs) that affect changes in potential mechanisms underlying depression are being explored. This presentation will review the potential importance of neurocircuitry and neuroplasticity in MDD and discuss the potential utility of using digital mental health treatments (DMHTs) to target neurobiological emotional control systems.
Disclaimer: PsychU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and Lundbeck, LLC – committed supporters of the mental health treatment community. The opinions expressed by PsychU’s contributors are their own and are not endorsed or recommended by PsychU or its sponsors. The information provided through PsychU is intended for the educational benefit of mental health care professionals and others who support mental health care. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing PsychU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by PsychU. Some of the contributors may be paid consultants for OPDC, OAPI, and / or Lundbeck, LLC.
Request this program for your region or organization today! This live (online or in-person) presentation, and others like it, are available for free for Members. View our complete listing of presentations and programs by visiting our Custom Program Request page.
Request Program